Octanohydroxamic Acid CAS 7377-03-9 Caprylhydroxamic Acid

Name: Octanohydroxamic Acid CAS 7377-03-9 Caprylhydroxamic Acid
Brand: Zhejiang Multinpharma Co., Ltd.
SKU: 2231800595

Zhejiang, ChinaZhejiang Multinpharma Co., Ltd.

Negotiable

10 Gram

Sample price:US$100.00/gram.Request sample

Product profile

Customization

Available

CAS No.

7377-03-9

Formula

C8h17no2

Model NO.

CAS 7377-03-9

EINECS

230-936-7

Type

Synthesis Material Intermediates

Appearance

Powder

Quality

Refined

Colour

White

Sample

Small Quantities Available

Packing

PE Bag, Aluminium Foil Bag

Testing

HPLC,Gc,Nmr

Color

White

Transport Package

PE Bag, Foil Aluminum Bag, Cardboard Drum

Specification

10g, 20g, 50g, 100g, 500g

Trademark

Origin

China

HS Code

2937290090

Production Capacity

500kgs /Month

Company profile

Importers and ExportersPatents AwardedFlexible CustomizationProduction Process Visualization

Zhejiang Multinpharma Co., Ltd.

Zhejiang, China

Business Type: Manufacturer/FactoryExport Year: 2008-11-05Nearest Port: Shanghai, NingboAverage Response Time: ≤3.42hTerms of Payment: LC, T/T, PayPal, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DDP

AI-Powered supplier vetting

SummaryThe supplier is a technology-focused company with a range of certifications, strong customization capabilities, and a notable production capacity in pharmaceutical and chemical products. However, they lack overseas warehousing, showrooms, and participation in international trade shows. While financially credible, their innovation capability could be questioned due to the absence of new products in the past year.

Supplier typeThe supplier is a science and technology company specializing in pharmaceutical and chemical production technology services, as well as offering CRO customization and microreaction technology services.

CertificationsThe supplier holds several certifications, including BSCI, TS 16949, ISO 14001, ISO 9001, ISO 20000, GMP, and QC 080000, indicating robust management and quality systems.

After-Sales capabilityThe supplier has clear procedures for service capability assessment, corrective actions, and handling customer complaints, suggesting strong after-sales service capability.

Financial creditThe supplier has financial data available for the past three years, indicating consistent financial tracking and credibility.

R&D capabilityThe supplier has not introduced new products in the past year, which may suggest limited innovation capacity.

Production capacityThe supplier has significant production capacity in pharmaceutical and chemical materials, operating three production lines with an annual output of US$5 Million - US$10 Million.

Customization capabilityThe supplier offers extensive customization services, including ODM and OEM for popular brands, supported by flexible design capabilities.

Client casesThe supplier lacks overseas presence, as indicated by the absence of overseas warehouses, showrooms, and participation in trade shows, which might limit their customer reach.